| Senior Bridge Home Health Care, Inc | |
| 5070 N 6th Stsuite 148, Fresno, California 93710 | |
| (559) 549-4334 | |
| Not Available |
| Name | Senior Bridge Home Health Care, Inc |
|---|---|
| Location | 5070 N 6th Stsuite 148, Fresno, California |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 553169 |
| Ownership Type | Proprietary |
| Service Area Zip Codes |
| NPI Number | 1528419165 |
| Organization Name | SENIOR BRIDGE HOME HEALTH CARE, INC |
| Address | 155 E Shaw Ave Ste 204, Fresno, CA 93710 |
| Phone Number | 559-421-9552 |
News Archive
Political and ethical fights over human cloning may follow the latest stem cell therapy advance after scientists created embryos that are genetic copies of living people in an effort to treat diseases such as Alzheimer's.
DIACARTA Inc., a precision molecular diagnostics company headquartered in Richmond, California, today announced that it is launching a new suite of CE-IVD marked highly sensitive hydrolysis probe based QClamp assays for detection of common cancer mutations in genes, such as KRAS, NRAS, BRAF, EGFR, PIK3CA and JAK2, using tissue biopsyand liquid biopsy samples.
Life Technologies Corporation today announced the expansion to its TaqMan Mutation Detection Assays - highly sensitive and novel molecular analysis research tools designed to detect an additional 241 of the most common mutations in 21 cancer genes.
Researchers from the University of Virginia and the University of Vermont have discovered a means of inhibiting one of the world's most voracious parasites.
A survey of serogroup 6 Streptococcus pneumoniae isolates from children in China has identified no antibiotic-resistant clones, leading the authors to speculate that the isolates may be under antibiotic selective pressure.
› Verified 9 days ago
| Quality Rating: | Not Available* |
| * This measure currently does not have data or provider has been certified/recertified for less than 6 months. | |
News Archive
Political and ethical fights over human cloning may follow the latest stem cell therapy advance after scientists created embryos that are genetic copies of living people in an effort to treat diseases such as Alzheimer's.
DIACARTA Inc., a precision molecular diagnostics company headquartered in Richmond, California, today announced that it is launching a new suite of CE-IVD marked highly sensitive hydrolysis probe based QClamp assays for detection of common cancer mutations in genes, such as KRAS, NRAS, BRAF, EGFR, PIK3CA and JAK2, using tissue biopsyand liquid biopsy samples.
Life Technologies Corporation today announced the expansion to its TaqMan Mutation Detection Assays - highly sensitive and novel molecular analysis research tools designed to detect an additional 241 of the most common mutations in 21 cancer genes.
Researchers from the University of Virginia and the University of Vermont have discovered a means of inhibiting one of the world's most voracious parasites.
A survey of serogroup 6 Streptococcus pneumoniae isolates from children in China has identified no antibiotic-resistant clones, leading the authors to speculate that the isolates may be under antibiotic selective pressure.
› Verified 9 days ago
News Archive
Political and ethical fights over human cloning may follow the latest stem cell therapy advance after scientists created embryos that are genetic copies of living people in an effort to treat diseases such as Alzheimer's.
DIACARTA Inc., a precision molecular diagnostics company headquartered in Richmond, California, today announced that it is launching a new suite of CE-IVD marked highly sensitive hydrolysis probe based QClamp assays for detection of common cancer mutations in genes, such as KRAS, NRAS, BRAF, EGFR, PIK3CA and JAK2, using tissue biopsyand liquid biopsy samples.
Life Technologies Corporation today announced the expansion to its TaqMan Mutation Detection Assays - highly sensitive and novel molecular analysis research tools designed to detect an additional 241 of the most common mutations in 21 cancer genes.
Researchers from the University of Virginia and the University of Vermont have discovered a means of inhibiting one of the world's most voracious parasites.
A survey of serogroup 6 Streptococcus pneumoniae isolates from children in China has identified no antibiotic-resistant clones, leading the authors to speculate that the isolates may be under antibiotic selective pressure.
› Verified 9 days ago
Pro Home Health Location: 2350 W Shaw Ave Ste 103, Fresno, California 93711 Ratings: Phone: (559) 753-8181 | |
California Home Health Location: 6069 N First Street Suite 102, Fresno, California 93710 Ratings: Phone: (559) 000-0000 | |
Senior Bridge Home Health Care, Inc Location: 5070 N 6th Stsuite 148, Fresno, California 93710 Ratings: NA Phone: (559) 549-4334 | |
Avance Home Health, Inc Location: 1350 O Street, Ste 303, Fresno, California 93721 Ratings: Phone: (559) 255-9300 | |
Focus Health Location: 377 W Fallbrook Avenue, Suite 206, Fresno, California 93711 Ratings: Phone: (559) 432-2257 | |
Ardent Home Health & Palliative Care Location: 2040 N Winery Ave, Suite 101, Fresno, California 93703 Ratings: NA Phone: (559) 721-4402 |